CytoDyn Appoints Anthony D. Caracciolo as Chairman of the Board of Directors

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PORTLAND, Ore.--(BUSINESS WIRE)--CytoDyn Inc. (“CytoDyn”) (OTC QB: CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, today announced that Anthony D. Caracciolo has been appointed Chairman of the Board of Directors effective June 17, 2013. Past Chairman, Gregory A. Gould, will remain a member of the Board of Directors and continue to serve as Chair of the Audit Committee.

Help employers find you! Check out all the jobs and post your resume.

Back to news